Lovenox (enoxaparin) is now approved to prevent deep vein thrombosis in certain MEDICAL patients

Lovenox (enoxaparin) is now approved to prevent deep vein thrombosis in certain MEDICAL patients...not just surgical patients.

This new indication is for patients at risk for thrombosis during an acute illness...due to restricted mobility with other risk factors such as obesity or varicose veins.

Give these patients low-dose heparin...or Lovenox 40 mg once a day for up to 14 days to prevent thromboembolic complications.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote